EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

November 16, 2021
9:31 pm

EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

WATERTOWN, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today…

Click here to view the original article.

Global, Yahoo Entertainment

Share this article

A Look At Market Trends And Technical Indicators

February 25, 2026

Following Record $113M Revenue Year, Travala Launches Global Car Rentals with Crypto

February 25, 2026

Analysts See 55.91% Upside Potential In Software Innovator

February 25, 2026

EU regulator ESMA warns on crypto perpetuals. But also applies to tokenized stocks – Ledger Insights

February 25, 2026

what’s driving WBC stock as RBA rate bets build

February 25, 2026

Endowments eye crypto allocations amid tougher return outlook for traditional investments

February 25, 2026

Ontario Teachers’ pension shifts climate strategy from emissions to investments

February 25, 2026

Is Marzetti (MZTI) Pricing Look Stretched After Recent Share Price Rebound?

February 25, 2026